129 related articles for article (PubMed ID: 21319947)
1. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
Shojaku H; Watanabe Y; Mineta H; Aoki M; Tsubota M; Watanabe K; Goto F; Shigeno K
Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
[TBL] [Abstract][Full Text] [Related]
2. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
3. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
[TBL] [Abstract][Full Text] [Related]
4. The effect of the Meniett device in patients with Ménière's disease: long-term results.
Dornhoffer JL; King D
Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
[TBL] [Abstract][Full Text] [Related]
5. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
8. Summating potential and action potential ratio in Meniere's disease before and after treatment.
Orchik DJ; Shea JJ; Ge NN
Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of middle ear pressure therapy with the EFET01 device in patients with Ménière's disease and delayed endolymphatic hydrops in Japan.
Tram Anh D; Takakura H; Nakazato A; Morita Y; Shojaku H
Acta Otolaryngol; 2023 Oct; 143(10):840-844. PubMed ID: 37995205
[TBL] [Abstract][Full Text] [Related]
10. [Delayed endolymphatic hydrops].
Giannoni B; Pagnini P; Vannucchi P
Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
[TBL] [Abstract][Full Text] [Related]
11. Clinical long-term effects of Meniett pulse generator for Meniere's disease.
Huang W; Liu F; Gao B; Zhou J
Acta Otolaryngol; 2009 Aug; 129(8):819-25. PubMed ID: 18923942
[TBL] [Abstract][Full Text] [Related]
12. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
Thomsen J; Sass K; Odkvist L; Arlinger S
Otol Neurotol; 2005 Jan; 26(1):68-73. PubMed ID: 15699722
[TBL] [Abstract][Full Text] [Related]
13. Results of labyrinthectomy in the treatment of Menière's disease and delayed endolymphatic hydrops.
Yazdi AK; Rutka J
J Otolaryngol; 1996 Feb; 25(1):26-31. PubMed ID: 8816106
[TBL] [Abstract][Full Text] [Related]
14. [Local overpressure treatment reduces vestibular symptoms in patients with Menière's disease--secondary publication. A clinically randomised multicenter double-blind placebo-controlled study].
Thomsen JC; Sass K; Odkvist L; Arlinger S
Ugeskr Laeger; 2006 Jan; 168(4):378-80. PubMed ID: 16436239
[TBL] [Abstract][Full Text] [Related]
15. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops.
Kitahara T; Maekawa C; Kizawa K; Horii A; Doi K
Otol Neurotol; 2009 Sep; 30(6):812-9. PubMed ID: 19638944
[TBL] [Abstract][Full Text] [Related]
16. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
17. Meniett clinical trial: long-term follow-up.
Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of a novel middle ear pressure device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Nakazato A; Takakura H; Do TA; Ueda N; Takeda N; Watanabe Y; Shojaku H
Acta Otolaryngol; 2022 May; 142(5):388-394. PubMed ID: 35544580
[TBL] [Abstract][Full Text] [Related]
19. [Oxygen therapy in the long term treatment of Meniere's disease].
Fattori B; Nacci A; Casani A; Donati C; De Iaco G
Acta Otorhinolaryngol Ital; 2001 Feb; 21(1):1-9. PubMed ID: 11434218
[TBL] [Abstract][Full Text] [Related]
20. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.
Friedrichs I; Thornton AR
Laryngoscope; 2001 May; 111(5):857-60. PubMed ID: 11359166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
